Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Zerodha CASE Nifty 100 ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseZerodhaNippon India
NAV₹11.2248₹29.1863
NAV date20 Nov 202620 Nov 2026
History2.4 years5.4 years
Expense ratio0.3%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
1 month+11.63%+10.82%
3 months+5.15%+7.43%
6 months+9.29%+14.54%
YTD+0.89%+25.40%
1 year+0.66%+25.57%
3 years (CAGR)—+22.02%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch+4.31%+14.02%

Risk

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
Volatility—15.0%
Downside volatility—9.0%
Sharpe—1.04
Sortino—1.72
Calmar—1.33
Return / risk—1.47
Deepest fall−17.23%−20.98%
Days to recover630136
Below its high+0.00%−1.75%

Against benchmark

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
Alpha—+0.00%
Beta—1.00
R²—100.0%
Up capture—100.0%
Down capture—100.0%
Tracking error—0.0%
Information ratio——
Treynor—0.14

Consistency

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
Best 1-year+15.19%+65.21%
Middle 1-year+0.92%+13.46%
Worst 1-year−10.47%−15.30%
1-year periods with a loss41.6%25.8%
Middle 3-year—+20.51%
Positive months—61.1%
Best day+3.95%+3.64%
Worst day−3.25%−4.03%
Worst 5% day−1.44%−1.62%
Positive days52.6%54.4%
NAVs a year248248

SIP of ₹10,000 a month

Zerodha CASE Nifty 100 ETFNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,738
3-year XIRR—+19.58%
1-year XIRR+11.01%+34.31%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth